Biotricity Inc (BTCY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biotricity Inc (BTCY) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($415.63K) by net assets ($-31.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Biotricity Inc for the company's overall valuation and market capitalisation.
Biotricity Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Biotricity Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biotricity Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biotricity Inc ranked by their cash flow conversion efficiency. See Biotricity Inc cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Silla Sg Co. Ltd
KQ:025870
|
0.474x |
|
Bakrieland Development Tbk
JK:ELTY
|
0.014x |
|
Avalon GloboCare Corp.
NASDAQ:ALBT
|
-0.264x |
|
PBS Finanse SA
WAR:PBF
|
0.004x |
|
Atlantic Sapphire As
OL:ASA
|
-2.484x |
|
Group 107 Ltd
TA:G107
|
-0.165x |
|
Marin Software Inc
NASDAQ:MRIN
|
-0.305x |
|
Nexion Group Ltd
AU:NNG
|
-0.152x |
Annual Cash Flow Conversion Efficiency for Biotricity Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Biotricity Inc from 2014 to 2025. View Biotricity Inc (BTCY) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $-30.01 Million | $-2.38 Million | 0.079x | -64.49% |
| 2024-03-31 | $-29.98 Million | $-6.69 Million | 0.223x | -67.29% |
| 2023-03-31 | $-19.85 Million | $-13.55 Million | 0.683x | -90.34% |
| 2022-03-31 | $-2.14 Million | $-15.16 Million | 7.070x | +335.99% |
| 2021-03-31 | $-6.83 Million | $-11.08 Million | 1.622x | -38.12% |
| 2020-03-31 | $-3.00 Million | $-7.86 Million | 2.621x | -10.77% |
| 2019-03-31 | $-1.78 Million | $-5.22 Million | 2.937x | +110.44% |
| 2018-03-31 | $173.25K | $-4.87 Million | -28.136x | -3390.93% |
| 2017-03-31 | $-4.38 Million | $-3.75 Million | 0.855x | -46.06% |
| 2016-03-31 | $-1.24 Million | $-1.96 Million | 1.585x | +139.05% |
| 2015-03-31 | $340.00K | $-1.38 Million | -4.059x | -17150.20% |
| 2014-03-31 | $349.44K | $-8.22K | -0.024x | -- |
About Biotricity Inc
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more